ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,581Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 300

$550K Total Retail Price of All Prescriptions

Rank: 38 out of 300

300 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 300 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

40% of this provider’s 300 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

3% of this provider’s 6,954 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 4%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $81 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 984 406 S3 1 1
NEXIUM 386 228 2 17
POTASSIUM CHLORIDE 312 227 3 22
MELOXICAM 207 157 4 27
FUROSEMIDE 199 157 5 3
LEVOTHYROXINE SODIUM 198 141 6 9
CIPROFLOXACIN HCL 186 88 7 28
OMEPRAZOLE 183 90 8 11
TRAMADOL HCL 172 102 9 23
AZITHROMYCIN 162 79 10 72
METOPROLOL SUCCINATE 160 107 11 6
GABAPENTIN 156 110 12 7
METFORMIN HCL 150 95 13 19
SIMVASTATIN 138 103 14 5
AMLODIPINE BESYLATE 137 115 15 2
LISINOPRIL 134 91 16 4
ZOLPIDEM TARTRATE 134 101 16 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 122 70 18 64
TAMSULOSIN HCL 115 89 19 8
TRAZODONE HCL 106 74 20 65
CLONIDINE HCL 103 72 21 50
POLYETHYLENE GLYCOL 3350 101 85 22 47
METOPROLOL TARTRATE 99 73 23 13
LANTUS 97 54 24 125
CLOPIDOGREL 95 82 25 18
PANTOPRAZOLE SODIUM 93 78 26 35
SPIRIVA 92 68 27 84
AVODART 91 83 28 67
CARAFATE 86 73 29 306
TORSEMIDE 85 66 30 188
PRAVASTATIN SODIUM 81 71 31 15
ADVAIR DISKUS 76 52 32 60
CYCLOBENZAPRINE HCL 76 29 R 32 71
PLAVIX 73 62 34 24
CITALOPRAM HBR 73 58 34 54
DIOVAN HCT 72 45 36 94
PROAIR HFA 70 32 37 138
DIGOXIN 68 55 38 39
CYMBALTA 68 22 38 37
ATENOLOL 67 67 40 31
VERAPAMIL ER 67 26 40 113
FAMOTIDINE 67 60 40 192
AMOXICILLIN 65 29 43 142
ALLOPURINOL 65 41 43 44
ESCITALOPRAM OXALATE 64 52 45 78
AMLODIPINE BESYLATE-BENAZEPRIL 62 41 46 52
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 39 46 70
ATORVASTATIN CALCIUM 62 44 46 14
DILTIAZEM ER 61 61 49 198
LYRICA 59 35 50 55
NAMENDA 57 57 51 48
DIOVAN 55 50 52 46
TRIAMCINOLONE ACETONIDE 54 33 53 228
CARVEDILOL 52 46 54 12
WARFARIN SODIUM 52 48 54 10
ENALAPRIL MALEATE 52 34 54 86
BACLOFEN 50 26 57 106
HYDROXYZINE HCL 50 31 R 57 445
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 27, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.